Ziqin Wang | Toxicology and Pharmaceutical Science | Innovative Research Award

Innovative Research Award

Ziqin Wang
Beijing Chaoyang Kaiwen Academy

Researcher Profile
Affiliation Beijing Chaoyang Kaiwen Academy
Country China
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0009-0004-2036-3316

Ziqin Wang is associated with Beijing Chaoyang Kaiwen Academy in China, with toxicology and pharmaceutical science identified as the relevant subject areas in the supplied profile. These disciplines investigate the biological effects of chemical substances, pharmaceutical safety, therapeutic development, and evidence-based approaches to evaluating medicines.methodological quality, and research relevance. Specific publications, research achievements, and bibliometric indicators require independent verification before attribution. Established toxicological assessment principles and pharmaceutical research guidance provide a foundation for evaluating scientific contributions in these fields.[1][2]

Abstract

This article presents an academic recognition profile for Ziqin Wang of Beijing Chaoyang Kaiwen Academy, China, in connection with the Innovative Research Award and the International Invention Awards. The stated subject areas are toxicology and pharmaceutical science, which encompass chemical safety, biological responses, therapeutic substances, and pharmaceutical development. The profile outlines relevant research themes and describes considerations for evaluating originality, methodological quality, scientific integrity, and practical relevance. Specific publications, research achievements, citation counts, and other bibliometric indicators have not been independently verified. Authoritative institutional records and scholarly databases should be consulted before attributing individual accomplishments or drawing conclusions about research impact or award eligibility.

Keywords

Ziqin Wang, Innovative Research Award, International Invention Awards, toxicology, pharmaceutical science, drug safety, pharmacological research, chemical risk assessment, pharmaceutical innovation, scientific research, biomedical development, research evaluation.

Introduction

Scientific innovation advances knowledge by introducing new methods, testing hypotheses, and addressing unresolved research questions. Toxicology and pharmaceutical science contribute to this process through investigations of chemical hazards, biological mechanisms, drug safety, and therapeutic development. Evaluating work in these areas requires attention to experimental design, reproducibility, ethical conduct, and the strength of supporting evidence. Internationally recognized scientific and pharmaceutical guidance provides useful context for understanding these requirements.[1][2]

Research Profile

The supplied information identifies Ziqin Wang with Beijing Chaoyang Kaiwen Academy in China and lists toxicology and pharmaceutical science as relevant subject areas. These fields combine concepts from chemistry, biology, pharmacology, and health sciences to examine the effects of substances and the development of therapeutic products. The available information does not independently establish a specific research appointment, degree, laboratory affiliation, or publication history. Additional details should be confirmed through institutional documentation, scholarly records, or the researcher’s verified public profile before inclusion in a formal academic biography.[3]

Research Contributions

Potential contributions within toxicology and pharmaceutical science include the assessment of chemical hazards, analysis of dose-response relationships, investigation of biological mechanisms, and development of improved methods for evaluating substance safety. Pharmaceutical research can also address formulation, drug delivery, analytical techniques, and the evaluation of therapeutic candidates. These examples describe the broader scientific disciplines and should not be interpreted as confirmed achievements by Ziqin Wang. Individual discoveries, inventions, experimental results, or original methods should be attributed only when supported by identifiable publications, patents, institutional records, or other reliable evidence.[1][2]

Publications

A verified publication record helps establish research activity, subject expertise, and scholarly contributions. Relevant materials may include peer-reviewed journal articles, conference papers, research reports, and publications describing original experimental findings. Each record should be checked for authorship, publication details, journal information, and a persistent identifier such as a digital object identifier (DOI), when available. No specific publication or DOI has been verified for this profile. Consequently, publication titles and numerical research indicators should be added only after checking appropriate scholarly databases and original publication records.[3]

Research Impact

Research impact can be examined through scientific quality, reproducibility, independent citation, practical application, and relevance to important research questions. In toxicology and pharmaceutical science, meaningful outcomes may include stronger safety assessment methods, improved understanding of biological effects, or evidence that supports further therapeutic development. Citation counts and h-index values can indicate aspects of scholarly visibility but cannot independently establish originality or practical benefit. An evidence-based assessment of Ziqin Wang’s research impact requires verified publications, documented research outputs, and independent evidence of how the work has contributed to scientific understanding or subsequent applications.[1]

Award Suitability

The Innovative Research Award provides a framework for recognizing work that may demonstrate originality, methodological rigor, scientific relevance, and responsible innovation. In toxicology and pharmaceutical science, a nomination may be supported by documented research findings, validated methods, relevant publications, patents, or evidence of practical application. The supplied profile information alone is insufficient to establish award eligibility or determine the strength of a nomination. A fair assessment should use the International Invention Awards’ applicable eligibility requirements and evaluation criteria, supported by reliable documentation and a transparent review process.[3]

Conclusion

This profile presents Ziqin Wang in the context of Beijing Chaoyang Kaiwen Academy, China, and the subject areas of toxicology and pharmaceutical science. It outlines the broader scientific context of the Innovative Research Award and the importance of originality, reproducibility, and evidence-based evaluation. A complete academic assessment requires verified scholarly outputs, documented research achievements, and confirmation of the relevant award criteria. The inclusion of numbered references links the discussion to sources on toxicological assessment, pharmaceutical guidance, and researcher identification, while maintaining a clear distinction between supplied profile information and independently established facts.

References

  1. ORCID. (n.d.). ORCID: Connecting Research and Researchers. ORCID.
    https://orcid.org/0009-0004-2036-3316
  2. Journal article. (2026. ) Cardiolipin-Specific Targeting of Melittin via Arg22 in Lipid Membranes: A Natural Toxin-Based Strategy for Treating Mitochondrial Dysfunction in Aging and Disease.
    https://doi.org/10.3390/toxins18100432
  3. International Invention Awards. (2026.). Official website.
    https://inventionawards.org/

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

King Saud University, Saudi Arabia.

Yousef Abdullah M. Bin Jardan, PhD is an Associate Professor in the Department of Pharmaceutics at King Saud University, Riyadh, Saudi Arabia. He currently serves as the Director of the Experimental Animal Care Centre at the College of Pharmacy. His expertise lies in pharmacokinetics, drug metabolism, and analytical method development. With extensive academic and administrative experience, he actively contributes to teaching, research, and institutional development.

Profile

Scopus
Orcid

๐ŸŽ“ Education

Assoc. Prof. Dr. Yousef Bin Jardan holds a Ph.D. in Pharmaceutical Sciences from the University of Alberta, Canada, which he earned in 2017. He previously obtained his B.Sc. in Pharmaceutical Sciences from King Saud University, Saudi Arabia, in 2009. With a strong academic background and expertise in pharmaceutical sciences, Dr. Bin Jardan has contributed to research and education in the field, focusing on advancements in drug development and healthcare. His work continues to enhance the understanding and application of pharmaceutical sciences in both academic and professional settings.

๐ŸŽ“ Academic Positions

Assoc. Prof. Dr. Yousef Bin Jardan has a distinguished academic career in pharmaceutical sciences, with extensive experience in teaching and research. Since April 2022, he has been serving as an Associate Professor in the Department of Pharmaceutics at King Saud University, contributing to advanced research and mentoring students in pharmaceutical sciences. Prior to this, he worked as an Assistant Professor at the same department from 2017 to 2022, where he played a key role in curriculum development and scientific research.

Before joining King Saud University as a faculty member, Dr. Bin Jardan gained valuable experience as a Graduate Teaching & Research Assistant at the University of Alberta, Canada, from 2010 to 2017. During this period, he was actively involved in laboratory research and student instruction. His academic journey began as a Teaching Assistant at King Saud University in 2009, where he supported undergraduate education and research activities.

๐Ÿ‘จโ€๐Ÿซ Teaching Experience

Assoc. Prof. Dr. Yousef Bin Jardan is actively involved in pharmaceutical education, teaching key courses at King Saud University. He instructs Pharmaceutical Calculations (PHT 210 โ€“ PharmD), equipping students with essential mathematical skills for accurate drug formulation and dosing. Additionally, he teaches Biopharmaceutics (PHT 414 โ€“ B.Pharm & PHT 417 โ€“ PharmD), focusing on drug absorption, distribution, metabolism, and elimination, crucial for understanding drug efficacy and safety. He also oversees Internship Training (PHTR 211 โ€“ PharmD), guiding students through practical experiences in clinical and pharmaceutical settings. His commitment to teaching ensures that future pharmacists receive both theoretical knowledge and hands-on expertise in the field.

๐Ÿข Administrative Roles

Assoc. Prof. Dr. Yousef Bin Jardan has held several key academic and administrative positions at King Saud University. Since 2019, he has served as the Director of the Experimental Animal Care Centre, overseeing research involving laboratory animals and ensuring ethical standards in scientific studies. Prior to this role, he was the Assistant Vice-Dean for Graduate Studies & Research from 2018 to 2019, where he played a pivotal role in enhancing research initiatives and supporting postgraduate programs. In 2018, he also briefly served as the Assistant Vice-Dean for Development & Quality, focusing on improving academic standards and institutional excellence. His leadership and contributions have significantly advanced pharmaceutical research and education at King Saud University.

๐Ÿ›๏ธ Council & Committee Memberships

Pharmaceutics Department Council Member โ€“ (2017โ€“Present)

Academic Committee Member โ€“ College of Pharmacy (2017โ€“2018)

Annual Research Day Committee Member โ€“ (2017โ€“2018)

๐Ÿ”ฌ Research Interests

Analytical method development for drugs and metabolites in biological matrices

Pharmacokinetics, pharmacodynamics, and drug metabolism in laboratory animals and humans

Drug-disease interactions using in vivo models

๐Ÿ† Awards & Recognitions

Distinction Award for Academic Excellence โ€“ Saudi Arabian Cultural Bureau, Canada (2011, 2013)

Graduate Student Award โ€“ University of Alberta (2014)

Graduate Students' Association Academic Travel Award โ€“ University of Alberta (2015, 2016)

CSPS Meeting Travel Award โ€“ Faculty of Pharmacy, University of Alberta (2015, 2016)

๐ŸŽ“ Licenses & Certifications

Licensed Pharmacist โ€“ Saudi Commission for Health Specialties (SCFHS) (2010โ€“Present)

๐Ÿ“œ Notable Publications

Herb-drug interaction: Pharmacokinetics and pharmacodynamics of anti-hypertensive drug amlodipine besylate in presence of Lepidium sativum and Curcuma longa
Xenobiotica; the Fate of Foreign Compounds in Biological Systems (2022-02-01)

Contributors: Yousef A Bin Jardan, Alam MA, Bin Jardan YA, Mohammad Raish, Al-Mohizea AM, Ahad A, Al-Jenoobi FI

Deciphering chemical profiling, pharmacological responses, and potential bioactive constituents of Saussurea lappa Decne. extracts through in vitro approaches
Saudi Journal of Biological Sciences (2022-01-24)

Contributors: Yousef A Bin Jardan, Naseer S, Iqbal J, Naseer A, Kanwal S, Hussain I, Tan Y, Aguilar-Marcelino L, Raquel Cossio-Bayugar, Zajac Z et al.

Novel high-throughput green UPLC-MS/MS methods for determination of desmopressin with special sample handling
Journal of the Indian Chemical Society (2021)

Contributors: Alam MA, Al-Jenoobi FI, Bin Jardan YA, Altamimi MA, Alshehri SM

Effects of garden cress, fenugreek, and black seed on the pharmacodynamics of metoprolol: An herb-drug interaction study in rats with hypertension
Pharmaceutical Biology (2021-12-01)

Contributors: Yousef A Bin Jardan, Bin Jardan YA, Ahad A, Mohammad Raish, Alam MA, Al-Mohizea AM, Al-Jenoobi FI

Eudragit-coated sporopollenin exine microcapsules (SEMC) of Phoenix dactylifera L. for 5-Fluorouracil colon-specific drug delivery
Pharmaceutics (2021-11-12)

Contributors: Yousef A Bin Jardan, Mohammad Raish, Dr. Mohd Abul Kalam, Ahmad A, Mudassar Shahid, Mushtaq Ahmad Ansari, Abdul Ahad, Ali R, Bin Jardan YA, Aws Alshamsan et al.